Organ Health Publications
Read Article
Resource Library
Natera Resource Hub - your source for articles and videos.
-
-
ctDNA-based molecular residual disease and survival in resectable colorectal cancer
Nakamura, et al. Nature Medicine 2024
Read Publication
-
Prospera Kidney MD Brochure
Read More
-
Renasight Patient Brochure
Discover how Renasight can provide valuable information about your kidney health.
Read More
-
Have a question or comment?
Contact Us -
Why Prospera Surveillance Brochure
The Prospera non-invasive blood test can comprehensively identify all types of active rejection with great precision.
Read More
-
Elevations of dd-cfDNA before bpAR ProActive Study Publication with Supplement April 2024
Bromberg, et al. Transplantation 2024
Read Publication
-
Renasight Provider Brochure
Learn about Renasight genetic testing and how it can provide valuable information for patient management of kidney disease.
Read More
-
How Dr. Yasir Qazi embraced cell-free DNA surveillance, an unaffected approach due to the recent CMS update
Hear from our ProActive Study Investigator In this episode of our Inside the ProActive Study Podcast, Dr. Yasir Qazi talks to us about: • His dd-cfDNA “surveillance journey” and protocol development.
Watch Video
-
How Dr. Yasir Qazi embraced cell-free DNA surveillance, an unaffected approach due to the recent CMS update - Audio Only
Hear from our ProActive Study Investigator In this episode of our Inside the ProActive Study Podcast, Dr. Yasir Qazi talks to us about his dd-cfDNA “surveillance journey” and protocol development.
Listen Now
-
How Dr. Matthew Cooper leverages dd-cfDNA to replace protocol biopsies for surveillance, in-line with ASTS recommended use
In this episode of our Inside the ProActive Study Podcast, Dr. Matthew Cooper shares his insights on: • Utilizing cfDNA alongside DSA and biopsies before implementing his dd-cfDNA surveillance protoc
Watch Video
-
How Dr. Matthew Cooper leverages dd-cfDNA to replace protocol biopsies for surveillance, in-line with ASTS recommended use
In this episode of our Inside the ProActive Study Podcast, Dr. Matthew Cooper shares his insights on: • Utilizing cfDNA alongside DSA and biopsies before implementing his dd-cfDNA surveillance...
Listen Now
-
How Dr. Millie Samaniego bridged the gap between study use and routine care by extending protocolized use
In this episode of our Inside the ProActive Study Podcast, Dr. Millie Samaniego-Picota tells us about: • Her experience expanding the ProActive Study Protocol schedule to all her patients • How her
Watch Video
-
How Dr. Millie Samaniego bridged the gap between study use and routine care by extending protocolized use
In this episode of our Inside the ProActive Study Podcast, Dr. Millie Samaniego-Picota tells us about: • Her experience expanding the ProActive Study Protocol schedule to all her patients • How her
Listen Now
-
Inside the ProActive Study- How Dr Sanjeev Akkina and Dr. Jessica Coleman approach the continuity of transplant recipient care
Watch Video
-
Inside the ProActive Study- How Dr Sanjeev Akkina and Dr. Jessica Coleman approach the continuity of transplant recipient care podcast
Listen Now
-
How Dr. Anand championed a surveillance protocol informed by his deep experience and research
Watch Video
-
How Dr. Anand championed a surveillance protocol informed by his deep experience and research
Listen Now
-
How Dr. Batarse advocates for his patients upon early recognition of subtle rejection using cfDNA
Watch Video
-
How Dr. Batarse advocates for his patients upon early recognition of subtle rejection using cfDNA
Listen Now
-
Women's Health Publications
Read Article
-
Carrier screening for Alport syndrome: The clinical importance of heterozygosity for pathogenic or likely pathogenetic variants
Souter, Vivienne; et al. J Genet Couns. 2025
Read Publication
-
Incidental finding of maternal sex chromosome aneuploidy from DMD carrier screening and single-nucleotide polymorphism (SNP)-based prenatal
Walker, J et al. J Genet Couns. 2025
Read Publication
-
Tiny Traces, Big Impact: Changing the Paradigm in Breast Cancer Management with MRD Testing
Watch Video
-
Using Circulating Tumor DNA to Monitor Sarcoma Treatment and Recurrence
Read More
-
Have a question or comment?
Contact Us -
Illuminating the CKD patient journey: Clinicogenomic data reshapes research & drug discovery
Chronic kidney disease (CKD) presents complex diagnostic and therapeutic challenges due to its heterogeneity and progressive nature. In this webinar, we explore how integrating genetic testing with re
Watch Video
-
Anti-slavery and Human Trafficking Statement
Read More
-
ASBrS APP Course
Signatera MRD testing in breast cancer setting
Watch Video
-
ASBrS Symposia
Signatera MRD testing in breast cancer setting
Watch Video
-
One Year of Prospera Hearth with DQS
Watch Video
-
GCs in Industry Webinar
Watch Video
-
Renasight - Variants of Uncertain Significance Video
This brief video will introduce you to genetic variant classification, with a focus on variants of uncertain significance (VUSes)
Watch Video
-
Signatera Genome Requisition
Please note: only an authorized healthcare provider can submit a test request for Signatera.
Read More
-
Clinical performance of Signatera Genome assay in a cohort of patients with solid tumors
George M, Schwartz G, McHayleh W, et al. ASCO Annual Meeting 2025, Chicago, IL. May 30 - June 3, 2025.
Read More
-
Cell-free DNA: The past, present, and future
Watch Video
-
Prospera Kidney DQS Case Study Series Long-term Post-tx and TCMR
Read More
-
Optimizing Patient Care in MIBC with MRD Testing, Real-world Clinical Cases
Watch Video
-
Transforming colorectal cancer management with tumor informed ctDNA testing
Listen Now
-
Low fetal fraction results for clinicians
A guide to discussing a result with low fetal fraction from Panorama NIPT with patients.
Watch Video
-
ISHLT 2025 clinical use of DQS Brent Lampert
Dr Lampert from Ohio State shares three key scenarios where DQS has added clinical value above and beyond traditional dd-cfDNA testing.
Watch Video
-
Loading More...
